APDN News and Press, Applied DNA Sciences Inc. From 08/14/25

Applied DNA Sciences Inc. (APDN) is expected to report for Q3 2025

STONY BROOK, NY / ACCESS Newswire / July 24, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in synthetic DNA manufacturing powered by scalable PCR platforms, today announced it received a seventh follow-on order valued at more than $600,000 for a m...

STONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the "Company"), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received written notice (the "Compliance Notice") from The Nasdaq Stock Market LLC ("Nasdaq") informin...

2025-06-30 10:31:03 ET More on Applied DNA Sciences Applied DNA Chairperson and CEO James A. Hayward resigns Applied DNA announces 1-for-15 reverse stock split Seeking Alpha’s Quant Rating on Applied DNA Sciences Historical earnings data for Applied DN...

- Conducts 27% Workforce Reduction, Ceases Operations at Applied DNA Clinical Labs, Positions LineaRx for Growth - STONY BROOK, NY / ACCESS Newswire / June 30, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN), a leader in PCR-based DNA technologies, announced a strategic restructuring an...

2025-06-17 16:15:05 ET More on Applied DNA Sciences Applied DNA announces 1-for-15 reverse stock split Applied DNA regains compliance with Nasdaq minimum bid price rule Seeking Alpha’s Quant Rating on Applied DNA Sciences Historical earnings data for A...

President and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that Chairpers...

STONY BROOK, NY / ACCESS Newswire / June 16, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will resume a regular quarterly investor call schedule, beginning with the release of its fiscal thir...

STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, is rescheduling its intra-quarter webcast and investor update call to June 17, 2025, from June 3, 2025...

2025-05-29 08:23:08 ET More on Applied DNA Sciences Applied DNA regains compliance with Nasdaq minimum bid price rule Applied DNA announces 1-for-50 reverse stock split Seeking Alpha’s Quant Rating on Applied DNA Sciences Read the full article on See...